Cleave Biosciences, Inc. — Form D
Cleave Biosciences, Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-18. The offering totals $20.8M, of which $12.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-06-18
- Form: D
- Accession: 0001682401-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.8M
- Amount sold: $12.0M
- Remaining: $8.8M
- Investors: 11
- Date of first sale: 2019-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342143
Issuer
- Name: Cleave Biosciences, Inc.
- CIK: 0001682401
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 863 Mitten Road, Suite 104, BURLINGAME, CA, 94010
- Phone: 650-443-3000
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Amy Burroughs | Director | Burlingame, CA |
| Jonathan Root | Director | Aliso Viejo, CA |
| Andrew Schwab | Director | BOSTON, MA |
| Laura Shawver | Director | Del Mar, CA |
| Peter Thompson | Director | Chanhassen, MN |
| Amy Burroughs | Executive Officer | Burlingame, CA |
| Carol Gallagher | Director | Carlsbad, CA |
| Laura Shawver | Executive Officer | Del Mar, CA |
| Timothy Smith | Executive Officer | Colchester, VT |
| Alfred Scheidegger | Director | Zurich, V8 |
| Mark Rolfe | Executive Officer | Burlingame, CA |
| Lewis Shuster | Director | Burlingame, CA |
| Dennis Henner | Director | Burlingame, CA |
Other filings by this issuer (1)
More